pyrazines has been researched along with Skin Diseases, Vascular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunsilius, E; Mitterer, M; Spizzo, G | 1 |
| Boral, A; Busam, K; Esseltine, D; Gerecitano, J; Gonen, M; Goy, A; MacGregor-Cortelli, B; Neylon, E; O'Connor, OA; Sachs, D; Schenkein, D; Teruya-Feldstein, J; Wright, J | 1 |
| Alomar, A; Dalmau, J; Fernández-Figueras, MT; Garcia-Navarro, X; Puig, L; Roe, E | 1 |
1 review(s) available for pyrazines and Skin Diseases, Vascular
| Article | Year |
|---|---|
Bortezomib-associated cutaneous vasculitis.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Female; Humans; Male; Middle Aged; Protease Inhibitors; Pyrazines; Skin Diseases, Vascular; Vasculitis | 2007 |
1 trial(s) available for pyrazines and Skin Diseases, Vascular
| Article | Year |
|---|---|
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?
Topics: Aged; Boronic Acids; Bortezomib; Drug Hypersensitivity; Female; Humans; Logistic Models; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Protease Inhibitors; Pyrazines; Skin; Skin Diseases, Vascular; Treatment Outcome | 2006 |
1 other study(ies) available for pyrazines and Skin Diseases, Vascular
| Article | Year |
|---|---|
Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia.
Topics: Adult; Aged; Boronic Acids; Bortezomib; Cryoglobulinemia; Humans; Male; Protease Inhibitors; Pyrazines; Skin Diseases, Vascular; Vasculitis | 2010 |